Miocardiopatías hereditarias

1 Davies MJ. The cardiomyopathies: an overview. Heart 2000; 83:469-74. 10.1136/heart.83.4.469 10722553

2 Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995; 92:785-9. 10.1161/01.CIR.92.4.785 7641357

3 Hada Y, Sakamoto T, Amano K, etal . Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening. Am J Cardiol 1987;59: 183-4. 10.1016/S0002-9149(87)80107-8 3812242

4 Maron BJ, Spirito P, Roman MJ, etal . Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study). Am J Cardiol 2004; 93:1510-4. 10.1016/j.amjcard.2004.03.007 15194022

5 Codd MB, Sugrue DD, Gersh BJ, Melton LJ3rd. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation 1989; 80:564-72. 10.1161/01.CIR.80.3.564 2766509

6 Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol 2013; 10:531-47. 10.1038/nrcardio.2013.105 23900355

7 Pilichou K, Thiene G, Bauce B, etal . Arrhythmogenic cardiomyopathy. Orphanet J Rare Dis 2016;11:33. 10.1186/s13023-016-0407-1. 27038780

8 Corrado D, Basso C, Judge DP. Arrhythmogenic Cardiomyopathy. Circ Res 2017;121:784-802. 10.1161/CIRCRESAHA.117.309345 28912183

9 Charron P, Elliott PM, Gimeno JR, etal. EORP Cardiomyopathy Registry Investigators. The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies. Eur Heart J 2018; 39:1784-93. 10.1093/eurheartj/ehx819 29378019

10 Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 1995; 26:1529-36. 10.1016/0735-1097(95)00353-3 7594081

11 Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 1999; 281:650-5.10.1001/jama.281.7.650 10029128

12 Association for Inherited Cardiac Conditions. General referral pathway. ttp://theaicc.org/ wp-content/uploads/2015/03/General-Referral-pathway.3.pdf.

13 Moak JP, Kaski JP. Hypertrophic cardiomyopathy in children. Heart 2012; 98:1044-54. 10.1136/heartjnl-2011-300531 22591735

14 Elkilany GE, Al-Qbandi MA, Sayed KA, Kabbash I. Dilated cardiomyopathy in children and adults: what is new? Scientific World Journal 2008;8:762-75. 10.1100/tsw.2008.105 18690380

15 Nava A, Bauce B, Basso C, et al. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2000; 36:2226-33.10.1016/S0735-1097(00)00997-9 11127465

16 Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation

2009;119:1085-92. 10.1161/CIRCULATIONAHA.108.804617 19221222

17 UK National Screening Committee. The UK NSC recommendation on screening to prevent Sudden Cardiac Death in 12 to 39 year olds. 2015. https://legacyscreening.phe.org.uk/suddencardiacdeath.

18 Corrado D, Pelliccia A, Bjørnstad HH, etal. Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Cardiovascular

pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Eur Heart J 2005;26:516-24.

10.1093/eurheartj/ehi108 15689345

19 Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006;296:1593-601.10.1001/jama.296.13.1593 17018804

20 Dhutia H, Malhotra A, Gabus V, etal . Cost implications of using different ECG criteria for screening young athletes in the United Kingdom. J Am Coll Cardiol 2016;68:702-11.10.1016/j.jacc.2016.05.076 27515329

21 Bagnall RD, Weintraub RG, Ingles J, etal. A prospective study of sudden cardiac death among children and young adults. N Engl J Med 2016; 374:2441-52.

10.1056/NEJMoa1510687 27332903

22 Basso C, Aguilera B, Banner J, etal. Association for European Cardiovascular Pathology. Guidelines for autopsy investigation of sudden cardiac death: 2017 update from the Association for European Cardiovascular Pathology. Virchows Arch 2017; 471:691-705. 10.1007/s00428-017-2221-0 28889247

23 de Noronha SV, Behr ER, Papadakis M, et al. The importance of specialist cardiac histopathological examination in the investigation of young sudden cardiac deaths. Europace 2014; 16:899-907. 10.1093/europace/eut329 24148315

24 Galea N, Carbone I, Cannata D, etal . Right ventricular cardiovascular magnetic resonance imaging: normal anatomy and spectrum of pathological findings. Insights Imaging 2013;4:213-23. 10.1007/s13244-013-0222-3 23389464

25 Bejar D, Colombo PC, Latif F, Yuzefpolskaya M. Infiltrative Cardiomyopathies. Clin Med Insights Cardiol 2015;9(Suppl 2):29-38.26244036

26 Lehrke S, Lossnitzer D, Schöb M, etal . Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart 2011;97:727-32. 10.1136/hrt.2010.205542 21097819

27 Ackerman MJ, Priori SG, Willems S, etal. Heart Rhythm Society (HRS)European Heart Rhythm Association (EHRA). HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace 2011;13:1077-109. 10.1093/europace/eur245 21810866

28 Marcus FI, McKenna WJ, Sherrill D, etal . Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 2010;121:1533-41.

29 te Riele ASJM, James CA, Groeneweg JA, etal . Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Eur Heart J 2016;37:755-63.10.1093/eurheartj/ehv387 26314686

30 Michels M, Hoedemaekers YM, Kofflard MJ, etal . Familial screening and geneticcounselling in hypertrophic cardiomyopathy: the Rotterdam experience. Neth Heart J 2007;15:184-90. 10.1007/BF03085978 17612681

31 Sweet M, Taylor MRG, Mestroni L. Diagnosis, prevalence, and screening of familial dilated cardiomyopathy. Expert Opin Orphan Drugs 2015; 3:869-76.

10.1517/21678707.2015.1057498 27547593

32 Christiaans I, van Langen IM, Birnie E, Bonsel GJ, Wilde AA, Smets EM. Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. Am J Med Genet A 2009; 149A:602-12. 10.1002/ajmg.a.32710 19253387

33 Aatre RD, Day SM. Psychological issues in genetic testing for inherited cardiovascular diseases. Circ Cardiovasc Genet 2011;4:81-90. 10.1161/CIRCGENETICS.110.957365 21325164

34 Government HM, and the Association of British Insurers. Code on Genetic Testing and Insurance. 2018. https://assets.publishing.service.gov.uk/government/uploads/system/ uploads/attachment_data/file/751230/code-on-genetic-testing-and-insurance.pdf.

35 Elliott PM, Anastasakis A, Borger MA, etal. Authors/Task Force members. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35:2733-79. 10.1093/eurheartj/ehu284 25173338